Infosys announced on Wednesday said it will acquire Denmark-based BASE Life Science for around 110 million euros (Rs 875 crore) in an all-cash deal. The acquisition will deepen Infosys' life sciences expertise and strengthen its presence across Europe.
“This acquisition enhances Infosys' expertise in deep life sciences, further expands our footprint in the Nordic region and across Europe, and extends our digital transformation capabilities with cloud-based industry solutions.
"We are excited to welcome BASE Life Sciences and its leadership team to the Infosys family," said Ravi Kumar S., President of Infosys.
The deal is expected to close during the second quarter of the current fiscal year.
BASE brings to Infosys domain experts with commercial, medical, digital, clinical, organizational and quality knowhow.
" Backed by a team of data science specialists, BASE is at the forefront of the latest technology developments and trends. It places a strong emphasis on data and artificial intelligence, and the ability to connect and integrate business logic and technology, resulting in knowledge for validating optimal results.”
"The company has around 200 of the industry's best multidisciplinary experts in Denmark, Switzerland, the UK, Germany, France and Italy, and an offshore technology center in Spain," the filing said.
In collaboration with Infosys, BASE will expand its portfolio of expertise in the consumer health, animal health, medical technology and genomics sectors.
“With Infosys as our catalyst, we will be able to accelerate our international expansion and create development opportunities for our employees,” said BASE life science CEO Martin Woergaard said.
We use necessary and (optional) analytics cookies on our websites to analyze traffic and personalize content.
do not want us to use optional cookies. We will set a cookie on your device to remember and honor your preference.1